CRON logo

CRON Cronos Group Inc.

NASDAQ Global Market · Drug Manufacturers - Specialty & Generic · Healthcare

$3.08
-0.09 (-2.84%)

Cronos Group Inc. functions as a diversified global cannabinoid enterprise. Within the United States, it manufactures, promotes, and distributes a variety of hemp-derived supplements and cosmetic products. These items are available under its Lord Jones and Happy Dance brands through online sales, traditional retail, and hospitality partner networks. The company also plays a significant role in the…

Market Cap: $1.13Bwww.thecronosgroup.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
47
6 mentions
—
60d
53
12 mentions
—
90d
51
16 mentions
—
news: 16

Analyst Ratings

15 analysts
Holdconsensus
Strong Buy 0Buy 3Hold 9Sell 3Strong Sell 0
Avg price target$2.3-25.3%
Low $2.3Median $2.3High $2.3
Current Consensus

Revenue

$63.45M+13528.13%
$465.6K$21.46M$42.46M$63.45M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$-0.00
$-0.00–$-0.00
2 analysts
FY2026
$0.18
$0.17–$0.19
3 analysts
FY2027
$0.18-2% YoY
$0.17–$0.19
3 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Michael Ryan Gorenstein
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
610
Beta
1.20
Country
CA
Piotroski score
7 / 9 (Strong)
Altman Z-score
10.82
www.thecronosgroup.com